This is a Validated Antibody Database (VAD) review about mouse Yap1, based on 171 published articles (read how Labome selects the articles), using Yap1 antibody in all methods. It is aimed to help Labome visitors find the most suited Yap1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Yap1 synonym: AI325207; Yap; Yap65; Yki; Yorkie

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (63.7)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 1a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology Inc, sc-101199) was used in western blot knockout validation on mouse samples at 1:1000 (fig 1a). elife (2018) ncbi
Abcam
(masked)
  • immunohistochemistry knockout validation; mouse; loading ...; fig s1
Abcam Yap1 antibody (Abcam, ab56701) was used in immunohistochemistry knockout validation on mouse samples (fig s1). elife (2017) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; zebrafish ; 1:200; loading ...; fig 2s2f
Cell Signaling Technology Yap1 antibody (CST, 4912) was used in immunohistochemistry knockout validation on zebrafish samples at 1:200 (fig 2s2f). elife (2020) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on human samples at 1:1000 (fig 4a). elife (2019) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig 1a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot knockout validation on mouse samples (fig 1a). Exp Mol Med (2018) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:500; loading ...; fig 4d
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on mouse samples at 1:500 (fig 4d). Exp Mol Med (2018) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s4b
MilliporeSigma Yap1 antibody (Sigma, Y4770) was used in western blot knockout validation on mouse samples at 1:1000 (fig s4b). PLoS Biol (2020) ncbi
Santa Cruz Biotechnology
mouse monoclonal (63.7)
  • western blot; human; 1:1000; loading ...; fig 5a
  • immunohistochemistry; mouse; loading ...; fig 5e, 5f
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in western blot on human samples at 1:1000 (fig 5a) and in immunohistochemistry on mouse samples (fig 5e, 5f). Theranostics (2022) ncbi
mouse monoclonal (63.7)
  • immunoprecipitation; human; loading ...; fig 5j
  • western blot; human; loading ...; fig s4c, s4d
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunoprecipitation on human samples (fig 5j) and in western blot on human samples (fig s4c, s4d). Nat Commun (2022) ncbi
mouse monoclonal (H-9)
  • chromatin immunoprecipitation; human; loading ...; fig 5i
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-271134) was used in chromatin immunoprecipitation on human samples (fig 5i). Nat Commun (2022) ncbi
mouse monoclonal (63.7)
  • western blot; mouse; 1:500; loading ...; fig 5a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in western blot on mouse samples at 1:500 (fig 5a). iScience (2022) ncbi
mouse monoclonal (63.7)
  • western blot; human; 1:1000; loading ...; fig s9e, s11
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in western blot on human samples at 1:1000 (fig s9e, s11). Nat Commun (2022) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; 1:100; loading ...; fig 6a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on mouse samples at 1:100 (fig 6a). Aging (Albany NY) (2022) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:200; loading ...; fig 6, s6
  • western blot; human; loading ...; fig 5b
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on human samples at 1:200 (fig 6, s6) and in western blot on human samples (fig 5b). iScience (2021) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; fig 4f
Santa Cruz Biotechnology Yap1 antibody (scbt, SC-101199) was used in immunocytochemistry on human samples (fig 4f). Commun Biol (2021) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; 1:50; loading ...
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on mouse samples at 1:50. Nat Commun (2021) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2b
Santa Cruz Biotechnology Yap1 antibody (Santa, sc101199) was used in immunohistochemistry - paraffin section on human samples (fig 2b). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; human; 1:100; loading ...; fig 4b
Santa Cruz Biotechnology Yap1 antibody (Santa cruz, Sc-101199) was used in immunohistochemistry on human samples at 1:100 (fig 4b). Nat Commun (2021) ncbi
mouse monoclonal (G-6)
  • western blot; mouse; 1:300; loading ...; fig 8a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-376830) was used in western blot on mouse samples at 1:300 (fig 8a). PLoS Genet (2021) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; 1:250; loading ...; fig 5a
  • western blot; mouse; 1:2000; loading ...; fig 5h
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, SC-101199) was used in immunocytochemistry on mouse samples at 1:250 (fig 5a) and in western blot on mouse samples at 1:2000 (fig 5h). Sci Adv (2021) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; 1:300; loading ...; fig 3d
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on mouse samples at 1:300 (fig 3d). Nat Commun (2021) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:100; loading ...; fig 1i
  • western blot; human; 1:1000; loading ...; fig 2b
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 5f
  • immunocytochemistry; mouse; 1:100; loading ...; fig 2f
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on human samples at 1:100 (fig 1i), in western blot on human samples at 1:1000 (fig 2b), in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 5f) and in immunocytochemistry on mouse samples at 1:100 (fig 2f). PLoS Biol (2021) ncbi
mouse monoclonal (63.7)
  • western blot; mouse; 1:200; loading ...; fig 7e
  • western blot; human; 1:200; loading ...; fig 8b
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in western blot on mouse samples at 1:200 (fig 7e) and in western blot on human samples at 1:200 (fig 8b). Mol Cell Biol (2021) ncbi
mouse monoclonal (63.7)
  • western blot; mouse; loading ...; fig 7a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in western blot on mouse samples (fig 7a). Theranostics (2021) ncbi
mouse monoclonal (G-6)
  • immunocytochemistry; human; 1:50; loading ...; fig 4d
  • western blot; human; 1:100; loading ...; fig 4c
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-376830) was used in immunocytochemistry on human samples at 1:50 (fig 4d) and in western blot on human samples at 1:100 (fig 4c). elife (2020) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:200; loading ...; fig 6c
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in immunocytochemistry on human samples at 1:200 (fig 6c). Cell Rep (2020) ncbi
mouse monoclonal (63.7)
  • western blot; mouse; 1:500; loading ...; fig s6a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in western blot on mouse samples at 1:500 (fig s6a). Commun Biol (2020) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; loading ...; fig 1b
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on human samples (fig 1b) and in western blot on human samples (fig 1a). elife (2020) ncbi
mouse monoclonal (63.7)
  • immunoprecipitation; human; loading ...; fig 2c
  • immunocytochemistry; human; loading ...; fig 1e
  • western blot; human; 1:500; loading ...; fig 1f
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunoprecipitation on human samples (fig 2c), in immunocytochemistry on human samples (fig 1e) and in western blot on human samples at 1:500 (fig 1f). J Exp Med (2020) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:200; fig e5r
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on human samples at 1:200 (fig e5r). Nature (2020) ncbi
mouse monoclonal
  • western blot; human; 1:250; loading ...; fig 4e
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-398182) was used in western blot on human samples at 1:250 (fig 4e). Front Oncol (2019) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 2c
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunohistochemistry on mouse samples at 1:50 (fig 2c). Cell Mol Gastroenterol Hepatol (2019) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:200; loading ...; fig 1b
  • western blot; human; 1:500; loading ...; fig 2e
Santa Cruz Biotechnology Yap1 antibody (Santa, sc-101199) was used in immunocytochemistry on human samples at 1:200 (fig 1b) and in western blot on human samples at 1:500 (fig 2e). Nat Commun (2019) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:200; loading ...; fig 3a
  • immunohistochemistry; zebrafish ; 1:200; loading ...; fig s7b
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in immunocytochemistry on human samples at 1:200 (fig 3a) and in immunohistochemistry on zebrafish samples at 1:200 (fig s7b). Nat Cell Biol (2019) ncbi
mouse monoclonal (63.7)
  • western blot; human; loading ...; fig 1f
Santa Cruz Biotechnology Yap1 antibody (Santa, sc-101199) was used in western blot on human samples (fig 1f). Curr Biol (2019) ncbi
mouse monoclonal (63.7)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 1a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology Inc, sc-101199) was used in western blot knockout validation on mouse samples at 1:1000 (fig 1a). elife (2018) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; loading ...; fig 3d
Santa Cruz Biotechnology Yap1 antibody (Santa, sc-101199) was used in immunocytochemistry on mouse samples (fig 3d). Oncogene (2019) ncbi
mouse monoclonal (G-6)
  • western blot; human; 1:100; loading ...; fig 1c
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, Inc, SC376830) was used in western blot on human samples at 1:100 (fig 1c). Mol Med Rep (2018) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:200; loading ...; fig s4i
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, 101199) was used in immunocytochemistry on human samples at 1:200 (fig s4i). Science (2018) ncbi
mouse monoclonal (63.7)
  • western blot; human; fig 1e
Santa Cruz Biotechnology Yap1 antibody (SantaCruz Biotechnology, sc-101199) was used in western blot on human samples (fig 1e). EMBO Rep (2018) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1a). J Histochem Cytochem (2018) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:100; loading ...; fig 5b
Santa Cruz Biotechnology Yap1 antibody (SantaCruz, sc-101199) was used in immunocytochemistry on human samples at 1:100 (fig 5b). J Cell Sci (2018) ncbi
mouse monoclonal (63.7)
  • western blot; human; 1:500; loading ...; fig 4b
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc101199) was used in western blot on human samples at 1:500 (fig 4b). Exp Cell Res (2018) ncbi
mouse monoclonal (63.7)
  • western blot; human; loading ...; fig 9e
Santa Cruz Biotechnology Yap1 antibody (SantaCruz, sc-101199) was used in western blot on human samples (fig 9e). J Clin Invest (2017) ncbi
mouse monoclonal
  • western blot; human; 1:1000; fig 5b
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-398182) was used in western blot on human samples at 1:1000 (fig 5b). Int J Mol Sci (2017) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:200; loading ...; fig s2c
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on human samples at 1:200 (fig s2c). Nat Commun (2017) ncbi
mouse monoclonal (63.7)
  • immunoprecipitation; human; loading ...; fig 3e
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc101199) was used in immunoprecipitation on human samples (fig 3e). Sci Rep (2017) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3b
In order to find that that Fat4 modulates Hippo signaling and restricts hearth growth in mice, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunohistochemistry on mouse samples at 1:100 (fig 3b). Nat Commun (2017) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig S61B
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunohistochemistry on mouse samples at 1:100 (fig S61B). elife (2017) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; dogs; loading ...; fig s3a
In order to develop optogenetic tools to upregulate and downregulate such forces with high spatiotemporal accuracy, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, 63.7) was used in immunohistochemistry on dogs samples (fig s3a). Nat Commun (2017) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:300; loading ...; fig 2d
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on human samples at 1:300 (fig 2d). EMBO Rep (2017) ncbi
mouse monoclonal (H-9)
  • western blot; human; loading ...; fig 3e
In order to find that frictional force characteristic of flow in the lymphatics stimulates YAP1 to drive cancer cell migration, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-271134) was used in western blot on human samples (fig 3e). Nat Commun (2017) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; human; fig 9d
In order to develop and assess corneal stromal Self-Lifting Analogous Tissue Equivalents (SLATEs), Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunohistochemistry on human samples (fig 9d). Biomaterials (2017) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; fig 1b
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on mouse samples (fig 1b). Cell (2016) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; mouse; 1:200
  • western blot; mouse; 1:1000
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, Sc-101199) was used in immunohistochemistry on mouse samples at 1:200 and in western blot on mouse samples at 1:1000. Nat Commun (2016) ncbi
mouse monoclonal (H-9)
  • chromatin immunoprecipitation; mouse
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, Sc-271134) was used in chromatin immunoprecipitation on mouse samples . Nat Commun (2016) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:75; fig s6
  • immunohistochemistry; human; 1:250
  • western blot; human; 1:500; fig 6a
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in immunocytochemistry on human samples at 1:75 (fig s6), in immunohistochemistry on human samples at 1:250 and in western blot on human samples at 1:500 (fig 6a). Nat Commun (2016) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; mouse; 1:150; fig 5
  • western blot; mouse; 1:2000; fig 5
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunohistochemistry on mouse samples at 1:150 (fig 5) and in western blot on mouse samples at 1:2000 (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 2b
In order to demonstrate that Rock regulates Hippo signaling and ensures the correct subcellular localization Amot in outer cells, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunohistochemistry on mouse samples at 1:100 (fig 2b). Reprod Biomed Online (2016) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; fig 5
  • western blot; human; fig 4
In order to study the production of a dominantly-acting oncogene in human breast cancer due to premature polyadenylation of MAGI3, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on human samples (fig 5) and in western blot on human samples (fig 4). elife (2016) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; 1:200; fig 1
In order to study the response to matrix rigidity by mechanical regulation of a molecular clutch that defines force transmission and transduction, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on mouse samples at 1:200 (fig 1). Nat Cell Biol (2016) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; 1:50; fig 3c
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on mouse samples at 1:50 (fig 3c). Stem Cells Int (2016) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry; human; fig 1h
  • western blot; human; loading ...; fig s1a
In order to study GSK3 inhibitor BIS I, YAP-dependent EMT signature in PDAC cell lines, and SMADs expression level, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunohistochemistry on human samples (fig 1h) and in western blot on human samples (fig s1a). Oncotarget (2016) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:400; fig 4
  • western blot; human; 1:1000; fig 3
In order to study the interaction with YAP1 in aggressive cancer types by ZEB1 turning into a transcriptional activator, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in immunocytochemistry on human samples at 1:400 (fig 4) and in western blot on human samples at 1:1000 (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:200; fig 4
  • western blot; human; 1:1000; fig 1
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunocytochemistry on human samples at 1:200 (fig 4) and in western blot on human samples at 1:1000 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human; 1:100; fig 7
  • western blot; human; 1:500; fig 7
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in immunocytochemistry on human samples at 1:100 (fig 7) and in western blot on human samples at 1:500 (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (63.7)
  • other; human; 1:200; loading ...
  • western blot; human; 1:200; loading ...
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in other on human samples at 1:200 and in western blot on human samples at 1:200. Oncotarget (2015) ncbi
mouse monoclonal (63.7)
  • immunoprecipitation; human; fig 2
  • western blot; human; fig 2
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunoprecipitation on human samples (fig 2) and in western blot on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (63.7)
  • western blot; human; loading ...; fig 4d
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc101199) was used in western blot on human samples (fig 4d). EMBO J (2015) ncbi
mouse monoclonal (63.7)
  • western blot; human
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc101199) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (63.7)
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in western blot on human samples (fig 3b). Nat Genet (2015) ncbi
mouse monoclonal (63.7)
  • western blot; human; 1:1000
In order to study the role of YAP in cell proliferation and survival using different cell types, Santa Cruz Biotechnology Yap1 antibody (Santa Cruiz Biotechnology, sc-101199) was used in western blot on human samples at 1:1000. PLoS ONE (2015) ncbi
mouse monoclonal (63.7)
  • western blot; human
In order to identify binding partners ANKHD1 in leukemia cells, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in western blot on human samples . Biochim Biophys Acta (2015) ncbi
mouse monoclonal (63.7)
  • western blot; mouse; fig 6j
Santa Cruz Biotechnology Yap1 antibody (Santa, sc-101199) was used in western blot on mouse samples (fig 6j). Dev Cell (2014) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; mouse; fig 8
In order to investigate if and how mTOR regulates YAP, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in immunocytochemistry on mouse samples (fig 8). J Exp Med (2014) ncbi
mouse monoclonal (H-9)
  • immunocytochemistry; mouse
In order to study the effect of the mechanical stiffness of the substrate on cell phenotypes, Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, H-9) was used in immunocytochemistry on mouse samples . Soft Matter (2014) ncbi
mouse monoclonal (63.7)
  • immunocytochemistry; human
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in immunocytochemistry on human samples . Cell Signal (2014) ncbi
mouse monoclonal (H-9)
  • immunocytochemistry; human; 1:200; fig 1
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-271134) was used in immunocytochemistry on human samples at 1:200 (fig 1). Cell (2014) ncbi
mouse monoclonal (63.7)
  • immunoprecipitation; human; fig 5
  • western blot; human; fig 5
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in immunoprecipitation on human samples (fig 5) and in western blot on human samples (fig 5). Cell (2014) ncbi
mouse monoclonal (63.7)
  • western blot; human
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz, sc-101199) was used in western blot on human samples . Exp Cell Res (2014) ncbi
mouse monoclonal (63.7)
  • immunohistochemistry - paraffin section; mouse; fig 1
  • western blot; mouse; fig s15
Santa Cruz Biotechnology Yap1 antibody (Santa Cruz Biotechnology, sc-101199) was used in immunohistochemistry - paraffin section on mouse samples (fig 1) and in western blot on mouse samples (fig s15). PLoS Genet (2013) ncbi
Abcam
domestic rabbit monoclonal (EPR19812)
  • western blot; human; loading ...
Abcam Yap1 antibody (Abcam, ab205270) was used in western blot on human samples . Theranostics (2022) ncbi
domestic rabbit monoclonal (EP1675Y)
  • western blot; human; loading ...
Abcam Yap1 antibody (Abcam, ab76252) was used in western blot on human samples . Theranostics (2022) ncbi
domestic rabbit monoclonal (EPR19812)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 7e
Abcam Yap1 antibody (Abcam, ab205270) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 7e). Nat Immunol (2022) ncbi
domestic rabbit monoclonal (EPR19812)
  • proximity ligation assay; mouse; 1:300; loading ...; fig 7b
Abcam Yap1 antibody (Abcam, ab205270) was used in proximity ligation assay on mouse samples at 1:300 (fig 7b). Nat Cancer (2022) ncbi
domestic rabbit monoclonal (EPR19812)
  • western blot; mouse; loading ...; fig 4f
Abcam Yap1 antibody (Abcam, ab205270) was used in western blot on mouse samples (fig 4f). Sci Adv (2022) ncbi
(masked)
  • western blot; human
Abcam Yap1 antibody (Abcam, ab56701) was used in western blot on human samples . Oxid Med Cell Longev (2021) ncbi
domestic rabbit monoclonal (EPR19812)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2c
Abcam Yap1 antibody (Abcam, ab205270) was used in immunohistochemistry - paraffin section on human samples (fig 2c). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EP1675Y)
  • western blot; human; fig 2f
Abcam Yap1 antibody (Abcam, ab76252) was used in western blot on human samples (fig 2f). Theranostics (2021) ncbi
domestic rabbit monoclonal (EPR19812)
  • western blot; human; 1:5000; loading ...; fig 6
Abcam Yap1 antibody (Abcam, ab205270) was used in western blot on human samples at 1:5000 (fig 6). Mol Med Rep (2021) ncbi
domestic rabbit monoclonal (EPR19812)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3a, 6g
Abcam Yap1 antibody (Abcam, ab205270) was used in immunohistochemistry on mouse samples at 1:200 (fig 3a, 6g). Nat Commun (2021) ncbi
domestic rabbit monoclonal (EPR19812)
  • immunohistochemistry - paraffin section; human; 1:2000; loading ...; fig 2a, 2c
Abcam Yap1 antibody (Abcam, ab205270) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 2a, 2c). Neoplasia (2021) ncbi
(masked)
  • immunohistochemistry; human; loading ...; fig 1b
  • western blot; human; loading ...; fig 1j
Abcam Yap1 antibody (Abcam, ab56701) was used in immunohistochemistry on human samples (fig 1b) and in western blot on human samples (fig 1j). Mol Cancer (2020) ncbi
domestic rabbit monoclonal (EP1675Y)
  • western blot; human; loading ...; fig 5d
Abcam Yap1 antibody (Abcam, ab76252) was used in western blot on human samples (fig 5d). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (EPR19812)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3s1a
Abcam Yap1 antibody (Abcam, ab205270) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3s1a). elife (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 6a
  • western blot; mouse; 1:1000; loading ...; fig 6c
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam Yap1 antibody (Abcam, ab62751) was used in immunohistochemistry on mouse samples at 1:100 (fig 6a), in western blot on mouse samples at 1:1000 (fig 6c) and in western blot on human samples at 1:1000 (fig 3a). J Clin Invest (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Abcam Yap1 antibody (Abcam, ab62751) was used in western blot on human samples (fig 1b). Proc Natl Acad Sci U S A (2018) ncbi
(masked)
  • immunohistochemistry knockout validation; mouse; loading ...; fig s1
Abcam Yap1 antibody (Abcam, ab56701) was used in immunohistochemistry knockout validation on mouse samples (fig s1). elife (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1 ug/ml; loading ...; fig 3d
  • western blot; human; 1:1000; loading ...; fig 3d
Abcam Yap1 antibody (Abcam, AB62751) was used in western blot on rat samples at 1 ug/ml (fig 3d) and in western blot on human samples at 1:1000 (fig 3d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP1675Y)
  • western blot; human; fig 1
Abcam Yap1 antibody (Abcam, ab76252) was used in western blot on human samples (fig 1). Oncotarget (2016) ncbi
domestic rabbit monoclonal (EP1675Y)
  • western blot; human; fig 1
In order to analyze protection of urothelial cell carcinoma from treatment-induced DNA damage via YAP activation, Abcam Yap1 antibody (Abcam, ab76252) was used in western blot on human samples (fig 1). Oncogene (2016) ncbi
domestic rabbit monoclonal (EP1675Y)
  • western blot; human; fig 5
Abcam Yap1 antibody (abcam, ab76252) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EP1675Y)
  • immunohistochemistry; mouse; 1:100
  • western blot; mouse; 1:10,000
Abcam Yap1 antibody (Abcam, ab76252) was used in immunohistochemistry on mouse samples at 1:100 and in western blot on mouse samples at 1:10,000. Cell Physiol Biochem (2015) ncbi
Abnova
mouse monoclonal (2F12)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 5a
In order to search for the cue that drives blastocyst embryonic lineage segregation, Abnova Yap1 antibody (Abnova, H00010413-M01) was used in immunohistochemistry on mouse samples at 1:100 (fig 5a). Dev Cell (2017) ncbi
mouse monoclonal (2F12)
  • immunocytochemistry; human; 1:100; loading ...; fig 3a
In order to find that frictional force characteristic of flow in the lymphatics stimulates YAP1 to drive cancer cell migration, Abnova Yap1 antibody (Abnova, H00010413-M01) was used in immunocytochemistry on human samples at 1:100 (fig 3a). Nat Commun (2017) ncbi
mouse monoclonal (2F12)
  • immunohistochemistry - frozen section; mouse; 1:60; loading ...; fig s3a
  • western blot; mouse; 1:500; loading ...; fig 3b
Abnova Yap1 antibody (Abnova, 2F12) was used in immunohistochemistry - frozen section on mouse samples at 1:60 (fig s3a) and in western blot on mouse samples at 1:500 (fig 3b). J Clin Invest (2017) ncbi
mouse monoclonal (2F12)
  • western blot; human; 1:400; loading ...; fig 10a
  • western blot; rat; 1:400; loading ...; fig 3b
Abnova Yap1 antibody (Abnova, H00010413-M01) was used in western blot on human samples at 1:400 (fig 10a) and in western blot on rat samples at 1:400 (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (2F12)
  • immunoprecipitation; human; loading ...; fig 5d
Abnova Yap1 antibody (Abnova, H00010413-M01) was used in immunoprecipitation on human samples (fig 5d). Oncotarget (2015) ncbi
mouse monoclonal (2F12)
  • immunoprecipitation; human; fig 1
Abnova Yap1 antibody (Taipei, H00010413-M01) was used in immunoprecipitation on human samples (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (2F12)
  • immunocytochemistry; mouse; 1:100
Abnova Yap1 antibody (Abnova, H00010413-M01) was used in immunocytochemistry on mouse samples at 1:100. Nat Commun (2014) ncbi
Novus Biologicals
domestic rabbit polyclonal (6C5cc)
  • chromatin immunoprecipitation; mouse; 1:1000; loading ...; fig 6a
Novus Biologicals Yap1 antibody (Novus Biologicals, 110-58358) was used in chromatin immunoprecipitation on mouse samples at 1:1000 (fig 6a). J Cell Sci (2021) ncbi
domestic rabbit polyclonal (6C5cc)
  • ChIP-Seq; mouse; loading ...; fig 5b
In order to test the role of YAP in branching morphogenesis for tissue patterning, Novus Biologicals Yap1 antibody (Novus, NB110-58358) was used in ChIP-Seq on mouse samples (fig 5b). elife (2017) ncbi
domestic rabbit polyclonal (6C5cc)
Novus Biologicals Yap1 antibody (Novus Biologicals, NB110-58358) was used . Oncotarget (2015) ncbi
R&D Systems
mouse monoclonal (867711)
  • immunocytochemistry; human; loading ...; fig 3e
R&D Systems Yap1 antibody (R&D, MAB8094) was used in immunocytochemistry on human samples (fig 3e). Drug Metab Dispos (2020) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 5
In order to examine the impact of FOXA1 to colorectal cancer, Invitrogen Yap1 antibody (Thermo Scientific, PA1-46189) was used in western blot on human samples at 1:1000 (fig 5). Mol Med Rep (2016) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4f
  • western blot; human; loading ...; fig s5e
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on mouse samples (fig 4f) and in western blot on human samples (fig s5e). Sci Adv (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4g
Cell Signaling Technology Yap1 antibody (Cell Signal, 4912) was used in western blot on human samples (fig 4g). Clin Transl Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 11
Cell Signaling Technology Yap1 antibody (Cell Signaling Technologies, 4911) was used in western blot on human samples at 1:1000 (fig 11). PLoS Pathog (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology Yap1 antibody (CST, 4912) was used in western blot on human samples at 1:1000 (fig 5c). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 5a). J Gynecol Oncol (2021) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:100; loading ...; fig 4g
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4912) was used in immunocytochemistry on mouse samples at 1:100 (fig 4g). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:50; loading ...; fig 3a
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4912) was used in western blot on mouse samples at 1:50 (fig 3a). Sci Adv (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 7d
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 7d). J Clin Invest (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6a, 6b
Cell Signaling Technology Yap1 antibody (CST, 4912) was used in western blot on human samples at 1:1000 (fig 6a, 6b). Am J Transl Res (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 1a). PLoS Biol (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911S) was used in western blot on human samples at 1:1000 (fig 5c). Cell Rep (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; zebrafish ; 1:200; loading ...; fig 2s2f
Cell Signaling Technology Yap1 antibody (CST, 4912) was used in immunohistochemistry knockout validation on zebrafish samples at 1:200 (fig 2s2f). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4d, 5f
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911S) was used in western blot on human samples (fig 4d, 5f). Cells (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1s2b, 1s3a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 1s2b, 1s3a). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7b
Cell Signaling Technology Yap1 antibody (CST, 4911) was used in western blot on mouse samples at 1:1000 (fig 7b). elife (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:200; loading ...; fig 7c
  • western blot; mouse; 1:200; loading ...; fig 7h
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunocytochemistry on mouse samples at 1:200 (fig 7c) and in western blot on mouse samples at 1:200 (fig 7h). EBioMedicine (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911S) was used in western blot on human samples (fig 7b). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4912) was used in western blot on human samples (fig 7b). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4d
Cell Signaling Technology Yap1 antibody (CST, 4911S) was used in western blot on mouse samples (fig 4d). Science (2019) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on human samples at 1:1000 (fig 4a). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig 4b). BMC Cancer (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 3b). Biomolecules (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig 3b). Biomolecules (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; zebrafish ; 1:400; loading ...; fig 1s1c
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunohistochemistry on zebrafish samples at 1:400 (fig 1s1c). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3b, 3j
Cell Signaling Technology Yap1 antibody (CST, 4911) was used in western blot on human samples at 1:1000 (fig 3b, 3j). elife (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 1c
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:500 (fig 1c). Stem Cells (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 6c
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4912) was used in western blot on mouse samples at 1:1000 (fig 6c). Cell Mol Gastroenterol Hepatol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4912) was used in western blot on human samples at 1:1000 (fig 3a). Cancer Manag Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 3a). Cancer Manag Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 8a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 8a). PLoS Biol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 8a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig 8a). PLoS Biol (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 3a). J Clin Invest (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911S) was used in western blot on human samples (fig 1f). Curr Biol (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 2f
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4912) was used in western blot on mouse samples at 1:1000 (fig 2f). Cell Death Dis (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 1b
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:500 (fig 1b). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples at 1:1000 (fig 4a). Invest Ophthalmol Vis Sci (2018) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000 (fig 5c). J Cell Sci (2018) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:500; loading ...; fig 4d
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on mouse samples at 1:500 (fig 4d). Exp Mol Med (2018) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig 1a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot knockout validation on mouse samples (fig 1a). Exp Mol Med (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 3b
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912S) was used in western blot on human samples at 1:500 (fig 3b). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 8c
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 8c). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2a). Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1b
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig 1b). Nat Genet (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 4b
Cell Signaling Technology Yap1 antibody (Cell signaling, 4912) was used in immunocytochemistry on human samples (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:150; loading ...; fig 4k
  • western blot; human; 1:1000; loading ...; fig s5d
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunocytochemistry on human samples at 1:150 (fig 4k) and in western blot on human samples at 1:1000 (fig s5d). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 2n
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunohistochemistry on mouse samples (fig 2n). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1fs2
In order to test the role of YAP in branching morphogenesis for tissue patterning, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911S) was used in immunohistochemistry on mouse samples at 1:100 (fig 1fs2). elife (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology Yap1 antibody (CST, 4911) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4e
In order to find that that Fat4 modulates Hippo signaling and restricts hearth growth in mice, Cell Signaling Technology Yap1 antibody (Cell signalling, 4912S) was used in western blot on mouse samples at 1:1000 (fig 4e). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4e
In order to find that that Fat4 modulates Hippo signaling and restricts hearth growth in mice, Cell Signaling Technology Yap1 antibody (Cell signalling, 4911) was used in western blot on mouse samples at 1:1000 (fig 4e). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2g
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig 2g). EMBO Rep (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...
In order to show a role for Hippo signaling in the epicardium in recruiting T regulatory cells post infarct, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912S) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3c
In order to find that frictional force characteristic of flow in the lymphatics stimulates YAP1 to drive cancer cell migration, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 3c). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:200; loading ...; fig 7a
In order to develop a method to generate semi-interpenetrating networks of polyacrylamide and recombinant basement membrane to culture human embryonic stem cells, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912S) was used in immunocytochemistry on human samples at 1:200 (fig 7a). Biomaterials (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 3b
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911) was used in western blot on mouse samples at 1:500 (fig 3b). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s4a
In order to report that DUB3 family deubiquitylating enzymes regulate Hippo pathway activity, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig s4a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s4a
In order to report that DUB3 family deubiquitylating enzymes regulate Hippo pathway activity, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig s4a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 3a
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911) was used in western blot on mouse samples at 1:500 (fig 3a) and in western blot on human samples at 1:1000 (fig 3b). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig 2b
  • western blot; mouse; 1:500; loading ...; fig 3a
  • western blot; human; 1:500; loading ...; fig 3b
Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4912) was used in immunohistochemistry on mouse samples at 1:200 (fig 2b), in western blot on mouse samples at 1:500 (fig 3a) and in western blot on human samples at 1:500 (fig 3b). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; zebrafish ; 1:200; loading ...; fig 5a
In order to propose that neurodevelopmental disorders and brain tumors may arise from changes in oncogenes, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on zebrafish samples at 1:200 (fig 5a). Dis Model Mech (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig 1i
  • western blot; mouse; 1:1000; loading ...; fig 1b
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911S) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 1i) and in western blot on mouse samples at 1:1000 (fig 1b). Nature (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 1a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 1a). Cell (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1a
  • western blot; human; loading ...; fig s1e
In order to demonstrate that the Hippo, Wnt/beta-catenin, and Notch pathways interact to regulate liver size and inhibit hepatocellular carcinoma, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on mouse samples (fig 1a) and in western blot on human samples (fig s1e). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s2f
In order to demonstrate that the Hippo, Wnt/beta-catenin, and Notch pathways interact to regulate liver size and inhibit hepatocellular carcinoma, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig s2f). J Clin Invest (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 1g
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 1g) and in western blot on human samples at 1:1000 (fig 1a). Gastroenterology (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 1g
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on mouse samples at 1:1000 (fig 1g) and in western blot on human samples at 1:1000 (fig 4a). Gastroenterology (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5h
Cell Signaling Technology Yap1 antibody (cell signalling, 4911) was used in western blot on human samples (fig 5h). J Clin Invest (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3b
  • western blot; mouse; 1:3000; loading ...; fig 3a
  • western blot; human; 1:3000; loading ...; fig 4c
Cell Signaling Technology Yap1 antibody (Cell signaling, 4912) was used in immunohistochemistry on mouse samples at 1:500 (fig 3b), in western blot on mouse samples at 1:3000 (fig 3a) and in western blot on human samples at 1:3000 (fig 4c). Neoplasia (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples at 1:100 (fig st1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:100; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:100 (fig st1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5A
In order to explore the role of NHERF1 in intestinal adenoma development, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 5A). Neoplasia (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 4E
  • immunohistochemistry - paraffin section; human; 1:100; fig 5B
  • western blot; human; fig 5A
In order to explore the role of NHERF1 in intestinal adenoma development, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4E), in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5B) and in western blot on human samples (fig 5A). Neoplasia (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
  • western blot; mouse; fig 2
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2) and in western blot on mouse samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 2
  • western blot; human; fig 2
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on mouse samples (fig 2) and in western blot on human samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:400; loading ...; fig 4e
  • western blot; rat; loading ...; fig 4c
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunohistochemistry - paraffin section on rat samples at 1:400 (fig 4e) and in western blot on rat samples (fig 4c). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig 4e
  • western blot; rat; loading ...; fig 4c
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 4e) and in western blot on rat samples (fig 4c). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:150; fig 6
  • western blot; mouse; 1:2000; fig s3
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in immunohistochemistry on mouse samples at 1:150 (fig 6) and in western blot on mouse samples at 1:2000 (fig s3). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 4
In order to investigate mechanisms that regulate myelin growth and nerve conduction, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; fig 2
  • western blot; mouse; 1:1000; fig 4
In order to investigate mechanisms that regulate myelin growth and nerve conduction, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunohistochemistry on mouse samples at 1:200 (fig 2) and in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7g
In order to study interaction between the p38 mitogen-activated protein kinase pathway and the Hippo pathway, Cell Signaling Technology Yap1 antibody (Cell Signalling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 7g). J Mol Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1c
  • western blot; mouse; fig 5a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig 1c) and in western blot on mouse samples (fig 5a). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 1a). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7c
In order to investigate the contribution of YAP in mouse neocortical astrocytic differentiation and proliferation, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 7c). Development (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3d
  • western blot; rat; 1:1000; loading ...; fig 3d
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000 (fig 3d) and in western blot on rat samples at 1:1000 (fig 3d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:100; fig s10
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s10). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:200; fig 2
Cell Signaling Technology Yap1 antibody (Cell Signaling Tech, 4912) was used in immunocytochemistry on human samples at 1:200 (fig 2). Oncol Lett (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology Yap1 antibody (Cell signaling, 4911) was used in western blot on human samples (fig 1). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
In order to study the production of a dominantly-acting oncogene in human breast cancer due to premature polyadenylation of MAGI3, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 5). elife (2016) ncbi
domestic rabbit polyclonal
  • western blot; chicken; 1:1000; fig 7
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911S) was used in western blot on chicken samples at 1:1000 (fig 7). BMC Biol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 2
In order to propose that epithelial tension and matricellular fibrosis contribute to the aggressiveness of SMAD4 mutant pancreatic tumors, Cell Signaling Technology Yap1 antibody (Cell signaling, 4912) was used in immunohistochemistry on mouse samples (fig 2). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 5
Cell Signaling Technology Yap1 antibody (Cell signaling, 4912) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 5). Front Physiol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 5
Cell Signaling Technology Yap1 antibody (Cell signaling, 4911S) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 5). Front Physiol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2d
In order to study GSK3 inhibitor BIS I, YAP-dependent EMT signature in PDAC cell lines, and SMADs expression level, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2d). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 5
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 5). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology Yap1 antibody (Cell signaling, 4911) was used in western blot on human samples at 1:1000 (fig 1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:50; fig 6
  • immunocytochemistry; mouse; 1:50; fig 6
In order to report that NEK8 human mutations cause major organ developmental defects, altered ciliogenesis, disrupted cell differentiation and proliferation, and deregulation of the Hippo pathway, Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911) was used in immunocytochemistry on human samples at 1:50 (fig 6) and in immunocytochemistry on mouse samples at 1:50 (fig 6). PLoS Genet (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 2
In order to study a kidney-specific knockout of Sav1 in the mouse suppresses the Hippo pathway which promotes hyperproliferation of renal tubular epithelium, Cell Signaling Technology Yap1 antibody (Cell signaling, 4912) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2). J Pathol (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s6
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig s6). Cell Signal (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to study the interaction with YAP1 in aggressive cancer types by ZEB1 turning into a transcriptional activator, Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
In order to investigate Tead4-mediated transcriptional networks in various types of cancer cells, Cell Signaling Technology Yap1 antibody (Cell signaling, 4911) was used in western blot on human samples (fig 4). Cell Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to investigate Tead4-mediated transcriptional networks in various types of cancer cells, Cell Signaling Technology Yap1 antibody (Cell signaling, 4912) was used in western blot on human samples (fig 3). Cell Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to analyze AMOTL1 and how it is antagonized by Merlin and promotes breast cancer progression, Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on human samples (fig 3). Neoplasia (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 3
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7
  • western blot; mouse; fig 4
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 7) and in western blot on mouse samples (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4
  • western blot; human; fig 7
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4912) was used in western blot on mouse samples (fig 4) and in western blot on human samples (fig 7). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
In order to study the activation mechanisms of core Hippo pathway components, Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples (fig 3). EMBO Rep (2016) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; human; fig 4
  • western blot; human; fig 2
In order to study the activation mechanisms of core Hippo pathway components, Cell Signaling Technology Yap1 antibody (Cell Signaling Technology, 4912) was used in immunoprecipitation on human samples (fig 4) and in western blot on human samples (fig 2). EMBO Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000
Cell Signaling Technology Yap1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000. Oncogene (2016) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s4b
MilliporeSigma Yap1 antibody (Sigma, Y4770) was used in western blot knockout validation on mouse samples at 1:1000 (fig s4b). PLoS Biol (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:500; loading ...; fig 7j
  • western blot; human; 1:500; loading ...; fig 4b
In order to study lncBRM and YAP1 signaling in liver cancer stem cells and hepatocellular carcinoma, MilliporeSigma Yap1 antibody (Sigma, Y4770) was used in immunohistochemistry on human samples at 1:500 (fig 7j) and in western blot on human samples at 1:500 (fig 4b). Nat Commun (2016) ncbi
Articles Reviewed
  1. Lu Y, Mu Y, Chen J, Guan X, Guo L, Wu C. CLP36 promotes p53 deficient sarcoma progression through suppression of atrophin-1 interacting protein-4 (AIP-4)-dependent degradation of YAP1. Theranostics. 2022;12:5051-5068 pubmed publisher
  2. Park S, Lee C, Choi J, Kim J, Lee W, Jang T, et al. Dysadherin awakens mechanical forces and promotes colorectal cancer progression. Theranostics. 2022;12:4399-4414 pubmed publisher
  3. Li X, Zhuo S, Zhuang T, Cho Y, Wu G, Liu Y, et al. YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis. Nat Commun. 2022;13:3075 pubmed publisher
  4. Fischer A, Wannemacher J, Christ S, Koopmans T, Kadri S, Zhao J, et al. Neutrophils direct preexisting matrix to initiate repair in damaged tissues. Nat Immunol. 2022;23:518-531 pubmed publisher
  5. Kaplan M, Flucher B. Counteractive and cooperative actions of muscle β-catenin and CaV1.1 during early neuromuscular synapse formation. iScience. 2022;25:104025 pubmed publisher
  6. Dai J, Cimino P, Gouin K, Grzelak C, Barrett A, Lim A, et al. Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain. Nat Cancer. 2022;3:25-42 pubmed publisher
  7. Esposito D, Pant I, Shen Y, Qiao R, Yang X, Bai Y, et al. ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation. Nat Commun. 2022;13:703 pubmed publisher
  8. Haroon M, Boers H, Bakker A, Bloks N, Hoogaars W, Giordani L, et al. Reduced growth rate of aged muscle stem cells is associated with impaired mechanosensitivity. Aging (Albany NY). 2022;14:28-53 pubmed publisher
  9. Kumar B, Adebayo A, Prasad M, Capitano M, Wang R, Bhat Nakshatri P, et al. Tumor collection/processing under physioxia uncovers highly relevant signaling networks and drug sensitivity. Sci Adv. 2022;8:eabh3375 pubmed publisher
  10. Zhang Y, He L, Huang L, Yao S, Lin N, Li P, et al. Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway. Clin Transl Med. 2021;11:e503 pubmed publisher
  11. Van Sciver N, Ohashi M, Pauly N, Bristol J, Nelson S, JOHANNSEN E, et al. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. PLoS Pathog. 2021;17:e1009783 pubmed publisher
  12. Savorani C, Malinverno M, Seccia R, Maderna C, Giannotta M, Terreran L, et al. A dual role of YAP in driving TGFβ-mediated endothelial-to-mesenchymal transition. J Cell Sci. 2021;134: pubmed publisher
  13. Mygland L, Brinch S, Strand M, Olsen P, Aizenshtadt A, Lund K, et al. Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines. iScience. 2021;24:102807 pubmed publisher
  14. Yuan Z, Ye L, Feng X, Zhou T, Zhou Y, Zhu S, et al. YAP-Dependent Induction of CD47-Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia-Reperfusion Injury. Oxid Med Cell Longev. 2021;2021:6617345 pubmed publisher
  15. Roper N, Velez M, Chiappori A, Kim Y, Wei J, Sindiri S, et al. Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer. Nat Commun. 2021;12:3880 pubmed publisher
  16. Pocaterra A, Scattolin G, Romani P, Ament C, Ribback S, Chen X, et al. Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development. Commun Biol. 2021;4:763 pubmed publisher
  17. Xiao L, Shi X, Li Z, Li M, Zhang M, Yan S, et al. Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway. J Gynecol Oncol. 2021;32:e77 pubmed publisher
  18. Jungwirth U, van Weverwijk A, Evans R, Jenkins L, Vicente D, Alexander J, et al. Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis. Nat Commun. 2021;12:3516 pubmed publisher
  19. Leach J, Vlahov N, Tsantoulis P, Ridgway R, Flanagan D, Gilroy K, et al. Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis. Nat Commun. 2021;12:3464 pubmed publisher
  20. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  21. Carter P, Schnell U, Chaney C, TONG B, Pan X, ye J, et al. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021;131: pubmed publisher
  22. Yuan T, Zheng R, Zhou X, Jin P, Huang Z, Zi X, et al. Abnormal Expression of YAP Is Associated With Proliferation, Differentiation, Neutrophil Infiltration, and Adverse Outcome in Patients With Nasal Inverted Papilloma. Front Cell Dev Biol. 2021;9:625251 pubmed publisher
  23. Zhang X, Yu K, Ma L, Qian Z, Tian X, Miao Y, et al. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. Theranostics. 2021;11:5650-5674 pubmed publisher
  24. Della Chiara G, Gervasoni F, Fakiola M, Godano C, D Oria C, Azzolin L, et al. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ. Nat Commun. 2021;12:2340 pubmed publisher
  25. Jin X, Zhu L, Xiao S, Cui Z, Tang J, Yu J, et al. MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker. Mol Med Rep. 2021;23: pubmed publisher
  26. Bi Lin K, Seshachalam P, Tuoc T, Stoykova A, Ghosh S, Singh M. Critical role of the BAF chromatin remodeling complex during murine neural crest development. PLoS Genet. 2021;17:e1009446 pubmed publisher
  27. Silver J, G xfc nay K, CUTLER A, Vogler T, Brown T, Pawlikowski B, et al. Injury-mediated stiffening persistently activates muscle stem cells through YAP and TAZ mechanotransduction. Sci Adv. 2021;7: pubmed publisher
  28. Jiang C, Javed A, Kaiser L, Nava M, Xu R, Brandt D, et al. Mechanochemical control of epidermal stem cell divisions by B-plexins. Nat Commun. 2021;12:1308 pubmed publisher
  29. Zhou R, Wu Q, Wang M, Irani S, Li X, Zhang Q, et al. The protein phosphatase PPM1A dephosphorylates and activates YAP to govern mammalian intestinal and liver regeneration. PLoS Biol. 2021;19:e3001122 pubmed publisher
  30. Hu Z, Chen Y, Huang M, Tu J, Tu S, Pan Y, et al. PLG inhibits Hippo signaling pathway through SRC in the hepatitis B virus-induced hepatocellular-carcinoma progression. Am J Transl Res. 2021;13:515-531 pubmed
  31. Delgado E, Erickson H, Tao J, Monga S, Duncan A, Anakk S. Scaffolding Protein IQGAP1 is Dispensable But Its Overexpression Promotes Hepatocellular Carcinoma via YAP1 Signaling. Mol Cell Biol. 2021;: pubmed publisher
  32. Han Z, Wang X, Xu Z, Cao Y, Gong R, Yu Y, et al. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1. Theranostics. 2021;11:3000-3016 pubmed publisher
  33. Mia M, Cibi D, Abdul Ghani S, Song W, Tee N, Ghosh S, et al. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. PLoS Biol. 2020;18:e3000941 pubmed publisher
  34. Muhammad J, Guimei M, Jayakumar M, Shafarin J, Janeeh A, AbuJabal R, et al. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival. Neoplasia. 2021;23:68-79 pubmed publisher
  35. Hao Q, Zong X, Sun Q, Lin Y, Song Y, Hashemikhabir S, et al. The S-phase-induced lncRNA SUNO1 promotes cell proliferation by controlling YAP1/Hippo signaling pathway. elife. 2020;9: pubmed publisher
  36. Seo G, Han H, Vargas R, Yang B, Li X, Wang W. MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation. Cell Rep. 2020;32:107860 pubmed publisher
  37. Jiao T, Yao X, Zhao Y, Zhou Y, Gao Y, Fan S, et al. Dexamethasone-Induced Liver Enlargement Is Related to PXR/YAP Activation and Lipid Accumulation but Not Hepatocyte Proliferation. Drug Metab Dispos. 2020;48:830-839 pubmed publisher
  38. Ye Z, Su Z, Xie S, Liu Y, Wang Y, Xu X, et al. Yap-lin28a axis targets let7-Wnt pathway to restore progenitors for initiating regeneration. elife. 2020;9: pubmed publisher
  39. Waaler J, Mygland L, Tveita A, Strand M, Solberg N, Olsen P, et al. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models. Commun Biol. 2020;3:196 pubmed publisher
  40. Rigiracciolo D, Nohata N, Lappano R, Cirillo F, Talia M, Scordamaglia D, et al. IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells. Cells. 2020;9: pubmed publisher
  41. Bae S, Ni L, Luo X. STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism. elife. 2020;9: pubmed publisher
  42. An L, Nie P, Chen M, Tang Y, Zhang H, Guan J, et al. MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway. J Exp Med. 2020;217: pubmed publisher
  43. Zhou T, Gao B, Fan Y, Liu Y, Feng S, Cong Q, et al. Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin. elife. 2020;9: pubmed publisher
  44. Jin D, Guo J, Wu Y, Yang L, Wang X, Du J, et al. m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020;19:40 pubmed publisher
  45. Chen F, Liu X, Chen Y, Liu J, Lu H, Wang W, et al. Sphere-induced reprogramming of RPE cells into dual-potential RPE stem-like cells. EBioMedicine. 2020;52:102618 pubmed publisher
  46. Diaz Cuadros M, Wagner D, Budjan C, Hubaud A, Tarazona O, Donelly S, et al. In vitro characterization of the human segmentation clock. Nature. 2020;580:113-118 pubmed publisher
  47. Kim J, Berrios C, Kim M, SCHADE A, Adelmant G, Yeerna H, et al. STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells. elife. 2020;9: pubmed publisher
  48. Yu S, Zhang Y, Li Q, Zhang Z, Zhao G, Xu J. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer. Cell Death Dis. 2019;10:949 pubmed publisher
  49. Moya I, Castaldo S, Van den Mooter L, Soheily S, Sansores Garcia L, Jacobs J, et al. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Science. 2019;366:1029-1034 pubmed publisher
  50. Zeng H, Castillo Cabrera J, Manser M, Lu B, Yang Z, Strande V, et al. Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. elife. 2019;8: pubmed publisher
  51. Hellinger J, Hüchel S, Goetz L, Bauerschmitz G, Emons G, Gründker C. Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion. Front Oncol. 2019;9:1074 pubmed publisher
  52. Fusco P, Parisatto B, Rampazzo E, Persano L, Frasson C, Di Meglio A, et al. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours. BMC Cancer. 2019;19:970 pubmed publisher
  53. Zhou L, Wang Q, Zhang H, Li Y, Xie S, Xu M. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine. Biomolecules. 2019;9: pubmed publisher
  54. Fillatre J, Fauny J, Fels J, Li C, Goll M, Thisse C, et al. TEADs, Yap, Taz, Vgll4s transcription factors control the establishment of Left-Right asymmetry in zebrafish. elife. 2019;8: pubmed publisher
  55. Park M, Kim A, Manandhar S, Oh S, Jang G, Kang L, et al. CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity. elife. 2019;8: pubmed publisher
  56. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  57. Gao C, Chen G, Zhang D, Zhang J, Kuan S, Hu W, et al. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-CateninY654. Cell Mol Gastroenterol Hepatol. 2019;8:561-578 pubmed publisher
  58. Quilichini E, Fabre M, Dirami T, Stedman A, De Vas M, Ozguc O, et al. Pancreatic ductal deletion of Hnf1b disrupts exocrine homeostasis, leads to pancreatitis and facilitates tumorigenesis. Cell Mol Gastroenterol Hepatol. 2019;: pubmed publisher
  59. Rong X, Han Q, Lin X, Kremerskothen J, Wang E. FRMPD1 activates the Hippo pathway via interaction with WWC3 to suppress the proliferation and invasiveness of lung cancer cells. Cancer Manag Res. 2019;11:3395-3410 pubmed publisher
  60. Lee J, Chang J, Dominguez A, Lee H, Nam S, Chang J, et al. YAP-independent mechanotransduction drives breast cancer progression. Nat Commun. 2019;10:1848 pubmed publisher
  61. Lodge E, Santambrogio A, Russell J, Xekouki P, Jacques T, Johnson R, et al. Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade. elife. 2019;8: pubmed publisher
  62. Miller C, Lou H, Simpson C, van de Kooij B, Ha B, Fisher O, et al. Comprehensive profiling of the STE20 kinase family defines features essential for selective substrate targeting and signaling output. PLoS Biol. 2019;17:e2006540 pubmed publisher
  63. Moro A, Driscoll T, Boraas L, Armero W, Kasper D, Baeyens N, et al. MicroRNA-dependent regulation of biomechanical genes establishes tissue stiffness homeostasis. Nat Cell Biol. 2019;21:348-358 pubmed publisher
  64. Li B, He J, Lv H, Liu Y, Lv X, Zhang C, et al. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow. J Clin Invest. 2019;129:1167-1179 pubmed publisher
  65. Rausch V, Bostrom J, Park J, Bravo I, Feng Y, Hay D, et al. The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae. Curr Biol. 2019;29:242-255.e6 pubmed publisher
  66. LeBlanc L, Lee B, Yu A, Kim M, Kambhampati A, Dupont S, et al. Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation. elife. 2018;7: pubmed publisher
  67. Pan W, Moroishi T, Koo J, Guan K. Cell type-dependent function of LATS1/2 in cancer cell growth. Oncogene. 2019;38:2595-2610 pubmed publisher
  68. Rivera Reyes A, Ye S, E Marino G, Egolf S, E Ciotti G, Chor S, et al. YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma. Cell Death Dis. 2018;9:1108 pubmed publisher
  69. Wu R, Yang H, Wan J, Deng X, Chen L, Hao S, et al. Knockdown of the Hippo transducer YAP reduces proliferation and promotes apoptosis in the Jurkat leukemia cell. Mol Med Rep. 2018;18:5379-5388 pubmed publisher
  70. Gut G, Herrmann M, Pelkmans L. Multiplexed protein maps link subcellular organization to cellular states. Science. 2018;361: pubmed publisher
  71. Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton B, et al. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun. 2018;9:2269 pubmed publisher
  72. Fan P, Narzisi G, Jayaprakash A, Venturini E, Robine N, Smibert P, et al. YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics. Proc Natl Acad Sci U S A. 2018;115:E6030-E6038 pubmed publisher
  73. Ho L, Skiba N, Ullmer C, Rao P. Lysophosphatidic Acid Induces ECM Production via Activation of the Mechanosensitive YAP/TAZ Transcriptional Pathway in Trabecular Meshwork Cells. Invest Ophthalmol Vis Sci. 2018;59:1969-1984 pubmed publisher
  74. Liu H, Dai X, Cao X, Yan H, Ji X, Zhang H, et al. PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expression. EMBO Rep. 2018;19: pubmed publisher
  75. Ahmed A, Habeebu S, Sherman A, Ye S, Wood N, Chastain K, et al. Potential Value of YAP Staining in Rhabdomyosarcoma. J Histochem Cytochem. 2018;66:577-584 pubmed publisher
  76. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  77. Ibar C, Kirichenko E, Keepers B, Enners E, Fleisch K, Irvine K. Tension-dependent regulation of mammalian Hippo signaling through LIMD1. J Cell Sci. 2018;131: pubmed publisher
  78. Lu L, Finegold M, Johnson R. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exp Mol Med. 2018;50:e423 pubmed publisher
  79. Liu L, Wu B, Cai H, Li D, Ma Y, Zhu X, et al. Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/?-catenin signaling. Exp Cell Res. 2018;362:532-540 pubmed publisher
  80. Zheng X, Dong Q, Zhang X, Han Q, Han X, Han Y, et al. The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer. Oncotarget. 2017;8:78734-78748 pubmed publisher
  81. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed publisher
  82. Skowron M, Niegisch G, Albrecht P, Van Koeveringe G, Romano A, Albers P, et al. Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines. Int J Mol Sci. 2017;18: pubmed publisher
  83. Toloczko A, Guo F, Yuen H, Wen Q, Wood S, Ong Y, et al. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. Cancer Res. 2017;77:4921-4933 pubmed publisher
  84. van Groningen T, Koster J, Valentijn L, Zwijnenburg D, Akogul N, Hasselt N, et al. Neuroblastoma is composed of two super-enhancer-associated differentiation states. Nat Genet. 2017;49:1261-1266 pubmed publisher
  85. Hadden W, Young J, Holle A, McFetridge M, Kim D, Wijesinghe P, et al. Stem cell migration and mechanotransduction on linear stiffness gradient hydrogels. Proc Natl Acad Sci U S A. 2017;114:5647-5652 pubmed publisher
  86. Nardone G, Oliver De La Cruz J, Vrbsky J, Martini C, Pribyl J, Skladal P, et al. YAP regulates cell mechanics by controlling focal adhesion assembly. Nat Commun. 2017;8:15321 pubmed publisher
  87. Watanabe Y, Miyasaka K, Kubo A, Kida Y, Nakagawa O, Hirate Y, et al. Notch and Hippo signaling converge on Strawberry Notch 1 (Sbno1) to synergistically activate Cdx2 during specification of the trophectoderm. Sci Rep. 2017;7:46135 pubmed publisher
  88. Lin C, Yao E, Zhang K, Jiang X, Croll S, Thompson Peer K, et al. YAP is essential for mechanical force production and epithelial cell proliferation during lung branching morphogenesis. elife. 2017;6: pubmed publisher
  89. Zhu G, Chen Y, Zhang X, Wu Q, Zhao Y, Chen Y, et al. 12-O-Tetradecanoylphorbol-13-acetate (TPA) is anti-tumorigenic in liver cancer cells via inhibiting YAP through AMOT. Sci Rep. 2017;7:44940 pubmed publisher
  90. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  91. Ragni C, Diguet N, Le Garrec J, Novotova M, Resende T, Pop S, et al. Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth. Nat Commun. 2017;8:14582 pubmed publisher
  92. Pósfai E, Petropoulos S, de Barros F, Schell J, Jurisica I, Sandberg R, et al. Position- and Hippo signaling-dependent plasticity during lineage segregation in the early mouse embryo. elife. 2017;6: pubmed publisher
  93. Valon L, Marín Llauradó A, Wyatt T, Charras G, Trepat X. Optogenetic control of cellular forces and mechanotransduction. Nat Commun. 2017;8:14396 pubmed publisher
  94. Heidary Arash E, Shiban A, Song S, Attisano L. MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells. EMBO Rep. 2017;18:420-436 pubmed publisher
  95. Korotkevich E, Niwayama R, Courtois A, Friese S, Berger N, Buchholz F, et al. The Apical Domain Is Required and Sufficient for the First Lineage Segregation in the Mouse Embryo. Dev Cell. 2017;40:235-247.e7 pubmed publisher
  96. Ramjee V, Li D, Manderfield L, Liu F, Engleka K, Aghajanian H, et al. Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction. J Clin Invest. 2017;127:899-911 pubmed publisher
  97. Grove M, Kim H, Santerre M, Krupka A, Han S, Zhai J, et al. YAP/TAZ initiate and maintain Schwann cell myelination. elife. 2017;6: pubmed publisher
  98. Lee H, Diaz M, Price K, Ozuna J, Zhang S, Sevick Muraca E, et al. Fluid shear stress activates YAP1 to promote cancer cell motility. Nat Commun. 2017;8:14122 pubmed publisher
  99. Gouveia R, González Andrades E, Cardona J, González Gallardo C, Ionescu A, Garzon I, et al. Controlling the 3D architecture of Self-Lifting Auto-generated Tissue Equivalents (SLATEs) for optimized corneal graft composition and stability. Biomaterials. 2017;121:205-219 pubmed publisher
  100. Price A, Huang E, Sebastiano V, Dunn A. A semi-interpenetrating network of polyacrylamide and recombinant basement membrane allows pluripotent cell culture in a soft, ligand-rich microenvironment. Biomaterials. 2017;121:179-192 pubmed publisher
  101. Hirai M, Arita Y, McGlade C, Lee K, Chen J, Evans S. Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. J Clin Invest. 2017;127:569-582 pubmed publisher
  102. Nguyen H, Kugler J, Cohen S. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins. PLoS ONE. 2017;12:e0169587 pubmed publisher
  103. Jerić I, Maurer G, Cavallo A, Raguz J, Desideri E, Tarkowski B, et al. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun. 2016;7:13781 pubmed publisher
  104. Mayrhofer M, Gourain V, Reischl M, Affaticati P, Jenett A, Joly J, et al. A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth. Dis Model Mech. 2017;10:15-28 pubmed publisher
  105. Wang L, Luo J, Li B, Tian X, Chen L, Huang Y, et al. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Nature. 2016;540:579-582 pubmed publisher
  106. Moroishi T, Hayashi T, Pan W, Fujita Y, Holt M, Qin J, et al. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016;167:1525-1539.e17 pubmed publisher
  107. Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B, et al. LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells. Nat Commun. 2016;7:13608 pubmed publisher
  108. Kim W, Khan S, Gvozdenovic Jeremic J, Kim Y, Dahlman J, Kim H, et al. Hippo signaling interactions with Wnt/?-catenin and Notch signaling repress liver tumorigenesis. J Clin Invest. 2017;127:137-152 pubmed publisher
  109. Kim H, Kim M, Park Y, Park I, Kim T, Yang S, et al. Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice. Gastroenterology. 2017;152:616-630 pubmed publisher
  110. Matsumoto Y, La Rose J, Kent O, Wagner M, Narimatsu M, Levy A, et al. Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2. J Clin Invest. 2016;126:4482-4496 pubmed publisher
  111. Zhang Q, Zhang Y, Parsels J, Lohse I, Lawrence T, Pasca di Magliano M, et al. Fbxw7 Deletion Accelerates KrasG12D-Driven Pancreatic Tumorigenesis via Yap Accumulation. Neoplasia. 2016;18:666-673 pubmed publisher
  112. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  113. Georgescu M, Gagea M, Cote G. NHERF1/EBP50 Suppresses Wnt-?-Catenin Pathway-Driven Intestinal Neoplasia. Neoplasia. 2016;18:512-23 pubmed publisher
  114. Vahid S, Thaper D, Gibson K, Bishop J, Zoubeidi A. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer. Sci Rep. 2016;6:31842 pubmed publisher
  115. Martin K, Pritchett J, Llewellyn J, Mullan A, Athwal V, Dobie R, et al. PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis. Nat Commun. 2016;7:12502 pubmed publisher
  116. Ruess D, Probst M, Marjanovic G, Wittel U, Hopt U, Keck T, et al. HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury. PLoS ONE. 2016;11:e0161233 pubmed publisher
  117. Kaukonen R, Mai A, Georgiadou M, Saari M, De Franceschi N, Betz T, et al. Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription. Nat Commun. 2016;7:12237 pubmed publisher
  118. Ma W, Jiang J, Li M, Wang H, Zhang H, He X, et al. The clinical significance of forkhead box protein A1 and its role in colorectal cancer. Mol Med Rep. 2016;14:2625-31 pubmed publisher
  119. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  120. Fernando R, Cotter L, Perrin Tricaud C, Berthelot J, Bartolami S, Pereira J, et al. Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway. Nat Commun. 2016;7:12186 pubmed publisher
  121. Mihajlovic A, Bruce A. Rho-associated protein kinase regulates subcellular localisation of Angiomotin and Hippo-signalling during preimplantation mouse embryo development. Reprod Biomed Online. 2016;33:381-90 pubmed publisher
  122. Huang D, Li X, Sun L, Huang P, Ying H, Wang H, et al. Regulation of Hippo signalling by p38 signalling. J Mol Cell Biol. 2016;8:328-37 pubmed publisher
  123. Feng X, Liu P, Zhou X, Li M, Li F, Wang Z, et al. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration. J Biol Chem. 2016;291:18947-58 pubmed publisher
  124. Huang Z, Hu J, Pan J, Wang Y, Hu G, Zhou J, et al. YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation. Development. 2016;143:2398-409 pubmed publisher
  125. Simile M, Latte G, Demartis M, Brozzetti S, Calvisi D, Porcu A, et al. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease. Oncotarget. 2016;7:49194-49216 pubmed publisher
  126. Liu C, Lin S, Hsu H, Yang S, Lin C, Yang M, et al. Suspension survival mediated by PP2A-STAT3-Col XVII determines tumour initiation and metastasis in cancer stem cells. Nat Commun. 2016;7:11798 pubmed publisher
  127. Qiao Y, Qian Y, Wang J, Tang X. Melanoma cell adhesion molecule stimulates yes-associated protein transcription by enhancing CREB activity via c-Jun/c-Fos in hepatocellular carcinoma cells. Oncol Lett. 2016;11:3702-3708 pubmed
  128. Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;291:14761-72 pubmed publisher
  129. Ni T, Kuperwasser C. Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer. elife. 2016;5: pubmed publisher
  130. McKey J, Martire D, de Santa Barbara P, Faure S. LIX1 regulates YAP1 activity and controls the proliferation and differentiation of stomach mesenchymal progenitors. BMC Biol. 2016;14:34 pubmed publisher
  131. Laklai H, Miroshnikova Y, Pickup M, Collisson E, Kim G, Barrett A, et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med. 2016;22:497-505 pubmed publisher
  132. Lodge E, Russell J, Patist A, Francis West P, Andoniadou C. Expression Analysis of the Hippo Cascade Indicates a Role in Pituitary Stem Cell Development. Front Physiol. 2016;7:114 pubmed publisher
  133. Elosegui Artola A, Oria R, Chen Y, Kosmalska A, Pérez González C, Castro N, et al. Mechanical regulation of a molecular clutch defines force transmission and transduction in response to matrix rigidity. Nat Cell Biol. 2016;18:540-8 pubmed publisher
  134. Cozzolino A, Noce V, Battistelli C, Marchetti A, Grassi G, Cicchini C, et al. Modulating the Substrate Stiffness to Manipulate Differentiation of Resident Liver Stem Cells and to Improve the Differentiation State of Hepatocytes. Stem Cells Int. 2016;2016:5481493 pubmed publisher
  135. Thongon N, Castiglioni I, Zucal C, Latorre E, D Agostino V, Bauer I, et al. The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level. Oncotarget. 2016;7:26551-66 pubmed publisher
  136. Keyvani Chahi A, Martin C, Jones N. Nephrin Suppresses Hippo Signaling through the Adaptor Proteins Nck and WTIP. J Biol Chem. 2016;291:12799-808 pubmed publisher
  137. Ma B, Cheng H, Gao R, Mu C, Chen L, Wu S, et al. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. Nat Commun. 2016;7:11123 pubmed publisher
  138. Grampa V, Delous M, Zaidan M, Odye G, Thomas S, Elkhartoufi N, et al. Novel NEK8 Mutations Cause Severe Syndromic Renal Cystic Dysplasia through YAP Dysregulation. PLoS Genet. 2016;12:e1005894 pubmed publisher
  139. Kai T, Tsukamoto Y, Hijiya N, Tokunaga A, Nakada C, Uchida T, et al. Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway. J Pathol. 2016;239:97-108 pubmed publisher
  140. Hoa L, Kulaberoglu Y, Gundogdu R, Cook D, Mavis M, Gomez M, et al. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling. Cell Signal. 2016;28:488-497 pubmed publisher
  141. Qin L, Dong Z, Zhang J. 14-3-3σ regulation of and interaction with YAP1 in acquired gemcitabine resistance via promoting ribonucleotide reductase expression. Oncotarget. 2016;7:17726-36 pubmed publisher
  142. Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498 pubmed publisher
  143. Liu X, Li H, Rajurkar M, Li Q, Cotton J, Ou J, et al. Tead and AP1 Coordinate Transcription and Motility. Cell Rep. 2016;14:1169-1180 pubmed publisher
  144. Couderc C, Boin A, Fuhrmann L, Vincent Salomon A, Mandati V, Kieffer Y, et al. AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin. Neoplasia. 2016;18:10-24 pubmed publisher
  145. Dai X, Zhuang L, Wang D, Zhou T, Chang L, Gai R, et al. Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells. Oncotarget. 2016;7:6933-47 pubmed publisher
  146. Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, et al. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proc Natl Acad Sci U S A. 2016;113:E71-80 pubmed publisher
  147. Kim M, Kim M, Park S, Lee C, Lim D. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. EMBO Rep. 2016;17:64-78 pubmed publisher
  148. Yang S, Zhang L, Purohit V, Shukla S, Chen X, Yu F, et al. Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 2015;6:36019-31 pubmed publisher
  149. Meng Z, Moroishi T, Mottier Pavie V, Plouffe S, Hansen C, Hong A, et al. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun. 2015;6:8357 pubmed publisher
  150. Brusgard J, Choe M, Chumsri S, Renoud K, MacKerell A, Sudol M, et al. RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells. Oncotarget. 2015;6:28132-50 pubmed publisher
  151. Ciamporcero E, Shen H, Ramakrishnan S, Yu Ku S, Chintala S, Shen L, et al. YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage. Oncogene. 2016;35:1541-53 pubmed publisher
  152. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  153. Choi H, Zhang H, Park H, Choi K, Lee H, Agrawal V, et al. Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2. Nat Commun. 2015;6:6943 pubmed publisher
  154. Tanas M, Ma S, Jadaan F, Ng C, Weigelt B, Reis Filho J, et al. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein. Oncogene. 2016;35:929-38 pubmed publisher
  155. Wang M, Liu Y, Zou J, Yang R, Xuan F, Wang Y, et al. Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β. Oncotarget. 2015;6:9517-30 pubmed
  156. Young K, Tweedie E, Conley B, Ames J, FitzSimons M, Brooks P, et al. BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses. PLoS ONE. 2015;10:e0122892 pubmed publisher
  157. Enzo E, Santinon G, Pocaterra A, Aragona M, Bresolin S, Forcato M, et al. Aerobic glycolysis tunes YAP/TAZ transcriptional activity. EMBO J. 2015;34:1349-70 pubmed publisher
  158. Ito T, Taniguchi H, Fukagai K, Okamuro S, Kobayashi A. Inhibitory mechanism of FAT4 gene expression in response to actin dynamics during Src-induced carcinogenesis. PLoS ONE. 2015;10:e0118336 pubmed publisher
  159. Lin L, Sabnis A, Chan E, Olivas V, Cade L, Pazarentzos E, et al. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat Genet. 2015;47:250-6 pubmed publisher
  160. Xiang C, Li J, Hu L, Huang J, Luo T, Zhong Z, et al. Hippo signaling pathway reveals a spatio-temporal correlation with the size of primordial follicle pool in mice. Cell Physiol Biochem. 2015;35:957-68 pubmed publisher
  161. Shen Z, Stanger B. YAP regulates S-phase entry in endothelial cells. PLoS ONE. 2015;10:e0117522 pubmed publisher
  162. Yang S, Zhang L, Chen X, Chen Y, Dong J. Oncoprotein YAP regulates the spindle checkpoint activation in a mitotic phosphorylation-dependent manner through up-regulation of BubR1. J Biol Chem. 2015;290:6191-202 pubmed publisher
  163. Machado Neto J, Lazarini M, Favaro P, de Melo Campos P, Scopim Ribeiro R, Franchi Junior G, et al. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. Biochim Biophys Acta. 2015;1853:583-93 pubmed publisher
  164. Li Q, Li S, Mana Capelli S, Roth Flach R, Danai L, Amcheslavsky A, et al. The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev Cell. 2014;31:291-304 pubmed publisher
  165. Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211:2249-63 pubmed publisher
  166. Ali M, Chuang C, Saif M. Reprogramming cellular phenotype by soft collagen gels. Soft Matter. 2014;10:8829-37 pubmed publisher
  167. Yu W, Qiao Y, Tang X, Ma L, Wang Y, Zhang X, et al. Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells. Cell Signal. 2014;26:2961-8 pubmed publisher
  168. Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. YAP/TAZ incorporation in the ?-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157-70 pubmed publisher
  169. Machado Neto J, Lazarini M, Favaro P, Franchi G, Nowill A, Saad S, et al. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells. Exp Cell Res. 2014;324:137-45 pubmed publisher
  170. Shao D, Zhai P, Del Re D, Sciarretta S, Yabuta N, Nojima H, et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315 pubmed publisher
  171. Reginensi A, Scott R, Gregorieff A, Bagherie Lachidan M, Chung C, Lim D, et al. Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet. 2013;9:e1003380 pubmed publisher